Skip to main content
Clinical Trials/ITMCTR2000003809
ITMCTR2000003809Not yet recruitingPhase 1

Clinical study on Bushen Huoxue Decoction in the treatment of peripheral neuropathy of multiple myeloma

Shanghai municipal Hospital of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 1) Multiple myeloma peripheral neuropathy was diagnosed;
  • 2) Aged between 25 and 85 years old;
  • 3) Conscious and willing to accept the trial treatment.

Exclusion Criteria

  • 1) Those who do not meet the inclusion criteria;
  • 2) Those who are allergic to the test drug;
  • 3) Patients with important organ dysfunction and mental disorders;
  • 4) Participants in other clinical drug trials;
  • 5) Those who suffer from mental illness or mental disorder and cannot be controlled.

Investigators

Similar Trials